Breakout Sessions
Track 1: The Business of PIV Disputes (available to in-person delegates only)Monitoring Legal Spend and Balancing the Budget
Track 2: The Practice of PIV Disputes (available to in-person and livestream delegates)Seeking Damages and Assessing Value Calculations
Track 1 - Speakers
Track 2 - Speaker
Serge Ilin-Schneider
Sr. Vice President, Corporate Development & General Counsel
Cosette Pharmaceuticals, Inc.
David Silverstein
Partner
Axinn, Veltrop & Harkrider LLP
Martin Wilson
General Counsel and Chief Compliance Officer
Rocket Pharmaceuticals
Shashank Upadhye
Partner
Upadhye Tang LLP
Robert McSorley
Managing Director
Ocean Tomo, LLC
Track 1: The Business of PIV Disputes — Monitoring Legal Spend and Balancing the Budget
- Implementing practices to minimize surprises and increase predictability
- Forecasting the budget by phase and quarter
- Knowing when to reevaluate use of task codes
- Deciding what components go into the budget
- Vendors
- Experts
- Understanding the source of error when surprises and overages occur
- Evaluating the appropriateness of alternative fee arrangements
Track 2: The Practice of PIV Disputes — Seeking Damages and Assessing Value Calculations
- Revisiting damages in an at- risk-launch scenario
- Exploring questions of royalties, lost profits and exceptional findings
- Examining grounds for mitigation
- Considering the practical consequences of the Supreme Court’s WesternGeco decision on Hatch-Waxman damages awards
- Exploring when U.S. patent owners may recover foreign lost profits tied to domestic acts of infringement under § 271(f)(2)
- Examining cases where the relevant infringing conduct occurred in the United States